[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507940":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":39,"responsibleParty":63,"collaborators":66,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":18,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":18,"enrollmentInfo":81,"targetDuration":18,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":92,"overallStatus":42,"whyStopped":18,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"The Reading Hospital and Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention arm","EXPERIMENTAL","Participants enrolled in the intervention arm will be given a 6-month access period to the diabetes education application designed by the study team. The web site will offer videos related to a specific areas of education concerning diabetes self-management. To encourage compliance, participant users will receive weekly notifications from the application that will guide them through viewing all videos in the series. Participants will continue routine follow-up appointments with their primary care physicians during the study period. There will be no restrictions on starting or stopping medications during the study period.",[13],"Other: Diabetes education web site application",{"label":15,"type":16,"description":17,"interventionNames":18},"Control arm","NO_INTERVENTION","Participants in the control arm will not have access to the Diabetes Application. They will continue follow-up appointments according to the standard of care with their primary care physician, diabetic educators, etc. There are no restrictions on starting or stopping medications for patients within the control arm.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Diabetes education web site application","The Diabetes education website application will contain informational videos for this protocol. The videos will include a welcome video and the categorical topics of Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes, and Disease Pathophysiology. Each category contains several videos providing education about a different component of diabetes care.",[9],[25],{"name":26,"affiliation":27,"role":28},"Luis A Murillo, MD, MPH","Reading Hospital Tower Health","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Mary E Alderfer, MSN","CONTACT","484-628-8360","mary.alderfer@towerhealth.org",{"name":36,"role":32,"phone":37,"phoneExt":18,"email":38},"Pamela Marrero","484-628-8355","pamela.marrero@towerhealth.org",[40],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Reading Hospital, an affiliate of Tower Health","RECRUITING","West Reading","Pennsylvania","19611","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-75.94743,40.3337,{"lat":52,"lon":51},[55,59,60],{"name":56,"role":32,"phone":57,"phoneExt":18,"email":58},"Research coordinator","484-628-8585","research@towerhealth.org",{"name":26,"role":28,"phone":18,"phoneExt":18,"email":18},{"name":61,"role":62,"phone":18,"phoneExt":18,"email":18},"Sally Snyder, MSN","SUB_INVESTIGATOR",{"type":28,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Luis Murillo","Residency Faculty Associate, Director Hanna Center for Primary Care Research",[67,70],{"name":68,"class":69},"Reading Hospital Foundation","UNKNOWN",{"name":71,"class":69},"Complete Statistical Services (Consult-Stat)","100507940","impact-of-a-diabetes-education-mobile-web-application-on-patients-with-uncontrolled-type-2-diabetes-100507940",false,"NCT05893927","Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes","Evaluating the Clinical Impact of a PCP Developed Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Diagnosis of Type 2 Diabetes with HA1c \\>8.0\n* Current patients of the Family Healthcare Center, Reading Hospital Tower health.\n\nExclusion Criteria:\n\n* Identified special populations (pregnancy or individuals currently incarcerated)\n* Patients without access to their own smart phone\n* Any patient who is unable to provide their own informed consent to participate in the study","ALL","18 Years",{"count":82,"type":83},65,"ESTIMATED","INTERVENTIONAL",[86],"NA","The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study.\n\nParticipants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study.\n\nParticipants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled.\n\nResearchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.",[89,90,91],"Diabetes Mellitus, Type 2","Diabetes Education","Lifestyle Modification",[93,94,95,96,97,98],"Type 2 diabetes","Type II diabetes","uncontrolled type 2 diabetes","hyperglycemia","mobile web application","Diabetes education","2025-07-25",{"date":101,"type":102},"2025-07-30","ACTUAL",{"date":104,"type":102},"2024-02-15",{"date":106,"type":83},"2026-09-30",{"name":5,"class":6},1]